Stocks Health care IVF
NASDAQ · Health careINVO Fertility, Inc. (IVF)
INVO Fertility, Inc. brought in $7.5M of revenue over the twelve months to June 30, 2026, up 13.1% from a year earlier. It posted a net loss of $7M. In fiscal 2025 capital spending exceeded operating cash flow by $7.1M. At June 30, 2026 it held $3.7M in cash against $1.6M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Key facts about INVO Fertility, Inc.
- Net worth
- INVO Fertility, Inc. has a market value (market cap) of $6.5M at the latest share price, and shareholders' equity of $16.5M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $6.8M (+4.3% year on year), with a net loss of $23.3M. Over the 12 months to June 30, 2026: revenue $7.5M, net loss $7M.
- Cash flow
- In fiscal 2025 operations used $7M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 14, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
What INVO Fertility, Inc. does
INVO Fertility, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker IVF.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $6.8M | -$23.3M | -$214.64 | -$7.1M |
| 2024 | $6.6M | -$9.3M | -$3,782.65 | -$3.2M |
| 2023 | $3M | -$8M | -$8,441.11 | -$5.2M |
| 2022 | $822.2K | -$10.9M | -$29,568.57 | -$6.6M |
| 2021 | $4.2M | -$6.7M | -$20,698.00 | -$6.4M |
| 2020 | $1M | -$8.3M | -$49,938.03 | -$4.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where IVF ranks in Health care
Latest SEC filings
What INVO Fertility, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 28, 2026
- August 28, 2026
- August 17, 2026
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 17% to $2.2M versus the same quarter last year; diluted EPS $0.35 versus -$364.23.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 7, 2026Passive stake (5% or more) SCHEDULE 13G
- July 24, 2026IPO registration S-1
- July 24, 2026
- June 25, 2026
- June 23, 2026Proxy statement DEF 14A
Insider trades
What the people running INVO Fertility, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| December 4, 2025 | Szot Matthew KDirector | Other change | 3 | - |
| December 3, 2025 | Szot Matthew KDirector | Sold | 4 | $6.1 |
Who owns IVF
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Alumni Capital LP13G, passive with 2 related filers | 9.99% | August 7, 2026 |
| Greenblock Capital, LLC13G, passive with 1 related filers | 9.99% | October 28, 2025 |
| Glenbrook Capital Management13G, passive | 8.33% | April 1, 2026 |
Largest institutional holders
Insiders
Questions about IVF
What does INVO Fertility, Inc. do?
INVO Fertility, Inc. is a company in the Health care sector, listed on NASDAQ as IVF. Its shares trade on NASDAQ under the ticker IVF.
What is INVO Fertility, Inc.'s net worth?
INVO Fertility, Inc. has a market value (market cap) of $6.5M at the latest share price, and shareholders' equity of $16.5M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is INVO Fertility, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $7M on revenue of $7.5M.
How much revenue does INVO Fertility, Inc. make?
Over the twelve months to June 30, 2026 INVO Fertility, Inc. reported revenue of $7.5M. That is 13.1% more than a year earlier.
When did INVO Fertility, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the employee stock plan registration from August 28, 2026.
Similar companies
Compare IVF with
Follow IVF
Get an email when INVO Fertility, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values INVO Fertility, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.